DS
CRMD icon

David Shaw’s CorMedix CRMD Stock Holding History

David Shaw’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Buy
+171,807
New +$1.36M ﹤0.01% 3538
2026
Q1 		– Sell
-106,374
Closed -$1.24M – 4622
2025
Q4 		$1.24M Buy
+106,374
New +$1.18M ﹤0.01% 3395
2025
Q3 		– Sell
-219,804
Closed -$2.71M – 4612
2025
Q2 		$2.71M Sell
219,804
-10,798
-5% -$119K ﹤0.01% 2514
2025
Q1 		$1.42M Sell
230,602
-215,812
-48% -$2.23M ﹤0.01% 2848
2024
Q4 		$3.62M Buy
446,414
+125,425
+39% +$1.25M ﹤0.01% 2246
2024
Q3 		$2.59M Buy
320,989
+190,745
+146% +$1.03M ﹤0.01% 2496
2024
Q2 		$564K Buy
130,244
+873
+0.7% +$4.43K ﹤0.01% 3551
2024
Q1 		$549K Sell
129,371
-13,906
-10% -$48.2K ﹤0.01% 3434
2023
Q4 		$539K Sell
143,277
-42,972
-23% -$148K ﹤0.01% 3479
2023
Q3 		$689K Buy
186,249
+134,945
+263% +$537K ﹤0.01% 3291
2023
Q2 		$203K Sell
51,304
-75,005
-59% -$371K ﹤0.01% 3733
2023
Q1 		$523K Sell
126,309
-18,527
-13% -$75.8K ﹤0.01% 3535
2022
Q4 		$611K Buy
144,836
+93,487
+182% +$331K ﹤0.01% 3744
2022
Q3 		$145K Buy
51,349
+37,529
+272% +$156K ﹤0.01% 4547
2022
Q2 		$56K Buy
13,820
+2,325
+20% +$8.64K ﹤0.01% 4826
2022
Q1 		$63K Buy
+11,495
New +$52.6K ﹤0.01% 5087
2021
Q1 		– Sell
-42,821
Closed -$318K – 4110
2020
Q4 		$318K Buy
+42,821
New +$291K ﹤0.01% 3581
2020
Q1 		– Sell
-30,306
Closed -$221K – 3971
2019
Q4 		$221K Buy
+30,306
New +$185K ﹤0.01% 3764

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

David Shaw's CRMD Position: Q2 2026 in Review

David Shaw opened a new position in CorMedix (CRMD) in Q2 2026: 171,807 shares worth $1.35M. The stake represents ﹤0.01% of the portfolio and ranks #3538 among its holdings. This is a return to the name: David Shaw previously reported a position in CRMD as recently as Q4 2025.

David Shaw first reported a position in CRMD in Q4 2019 and has held it in 18 quarters since. The position peaked at $3.62M in Q4 2024. 192 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • David Shaw held 171,807 shares of CorMedix worth $1.35M as of Q2 2026.
  • CorMedix was a new David Shaw position in Q2 2026.
  • CorMedix made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3538 holding.
  • David Shaw first reported a position in CorMedix in Q4 2019 and has held it in 18 quarters since.
  • David Shaw's CorMedix position peaked at $3.62M in Q4 2024.
  • 192 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.